Reyvow

Lasmiditan, sold under the brand name Reyvow, is a medication used for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults.[2] It is not useful for prevention.[2] It is taken by mouth.[2] Common side effects include sleepiness, dizziness, tiredness, and numbness.[3][4] Lasmiditan was approved in the United States in October 2019 ... [wikipedia]